Stay updated on Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.5 to v3.6.6, reflecting a minor version update to the page. This does not alter the study information or how the page operates.
    Difference
    0.0%
    Check dated 2026-08-30T21:59:34.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's revision label shows v3.6.5, replacing v3.6.4. This indicates a small metadata update to the page revision history without changing the study content.
    Difference
    0.0%
    Check dated 2026-08-09T08:18:27.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new revision tag, v3.6.4, has been added to replace the previous v3.6.3, signaling a minor site deployment update rather than changes to the study information.
    Difference
    0.0%
    Check dated 2026-07-25T17:56:58.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.6.2 to v3.6.3, reflecting a new page revision.
    Difference
    0.0%
    Check dated 2026-07-04T13:26:45.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Version bump from v3.6.0 to v3.6.2 indicates a new platform release. It likely includes internal fixes or refinements and does not imply changes to study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-27T07:37:48.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Enrollment is now closed with a note that participants are no longer being sought. The page's navigation and headings were updated (e.g., addition of 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and the formatting change from 'Intervention / Treatment' to 'Intervention/Treatment'), along with a page revision tag 'Revision: v3.6.0'.
    Difference
    0.4%
    Check dated 2026-06-13T00:27:35.000Z thumbnail image

Stay in the know with updates to Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.